ReviewRevista medica del Instituto Mexicano del Seguro Social2026
[Psychiatry as clinical neuroscience].
Review in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For more than a century, psychiatry has established its clinical practice on syndrome-based descriptions grouped into exclusive diagnostic categories and on the prescription of psychotropic drugs aimed at modifying signs and symptoms, with etiological hypotheses formulated from different theoretical frameworks, ranging from psychoanalytic to neurobiological. Recent research from a neuroscientific theoretical framework suggests that different psychiatric illnesses are interconnected at different levels. The approach to mental disorders from this new perspective has generated more precise etiological hypotheses, has favored the development of initiatives that recommend a radical change in psychiatric taxonomy, and has oriented pharmacological research to other therapeutic targets. This article raises the possibility of psychiatry being positioned as a clinical neuroscience based on studies on brain connectivity as a substrate of mental functioning (Human Connectome Project), transdiagnostic nosological classification initiatives from a dimensional and spectral perspective (Research Domain Criteria and Hierarchical Taxonomy of Psychopathology) the new psychopharmacological nomenclature based on neurosciences and the findings in genomic association studies. The paradigm shift for the approach to mental disorders also includes the training of specialists in psychiatry, which is why the inclusion of neuroscience subjects in medical residency programs is recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.